Clinical Trial Update: Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the tolerability and acceptability of rasagiline for early-stage Parkinson's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Qualissima | Conditions: Early-stage Parkinson's Disease | Phase 4 | Status: TERMINATED